Andere talen Creo Medical Group PLC

Aandelen

CREO

GB00BZ1BLL44

Beurs gesloten - London S.E. Andere beurzen 17:35:06 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
36,25 ^GBX	0,00%		+4,32%	-21,20%

24/04	Omzet ActiveOps omhoog; omzet Sancus springt omhoog	AN
01/03	Creo Medical Group plc kondigt een update aan over microgolf-longablatie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ActiveOps sales up; Sancus turnover jumps	24/04
Creo Medical says NHS case study reveals significant efficiencies from Speedboat technology	24/04
EARNINGS AND TRADING: Dar Global celebrates "outstanding" year	01/03
Creo Medical Group plc Announces Microwave Lung Ablation Update	01/03
Creo Medical Group expands reach of Speedboat UltraSlim; announces tie-up with Abu Dhabi university	12/02
Creo Medical ends "pivotal" 2023 year with clear path to cashflow breakeven	12/02
Creo Medical makes "considerable strides" toward 2025 break-even goal	07/02
Creo Medical partners with Khalifa University in Abu Dhabi	05/02
Creo Medical Group plc Announces Strategic Collaboration with Khalifa University of Science and Technology	05/02
Creo unveils product in APAC; Unilever hires director	31/01
Creo Medical Group plc Announces Continued Progress on the Phased Market Release of Its Latest Device, Speedboat® UltraSlim	31/01
Creo Medical's Speedboat UlstraSlim device used in Latin America	10/01
Creo Medical's SpeedBoat UltraSlim successfully used in US	15/12
Creo Medical Group plc Announces First Use of Speedboat UltraSlim in the USA	15/12
Good Energy says ZapMap expands into mainland Europe	13/12
Creo Medical Group PLC Announces the Initiation of Its Commercial Launch of Speedboat Ultraslim	13/12
Creo Medical Group reveals good growth prospects at Capital Markets Day - Proactive Research Analyst	27/11
Creo Medical CEO "very happy with where we are at the moment"	13/11
Creo Medical Wins US FDA Nod for Medical Endoscopy Device	01/11
Creo Medical Group plc Receives 510(K) Clearance from the Us Food & Drug Administration for Its Speedboat Ultraslim Device	01/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Creo Medical Group PLC

Aandelen

CREO

GB00BZ1BLL44

Andere talen

Filters